| 1 | [ACH-0144471] | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | 1件: 62 62 💬
|
| 2 | [ACT-HIB] | - | - | - | - | 2件: 62 62, 223 💬
|
| 3 | [ALN-CC5] | - | - | - | - | 2件: 11 11, 62 💬
|
| 4 | [ALXN1210] | - | - | - | - | 6件: 2 2, 11, 13, 50, 62, 66 💬
|
| 5 | [ALXN2040] | - | - | - | - | 1件: 62 62 💬
|
| 6 | [BCX9930] | - | - | - | - | 4件: 62 62, 66, 222, 223 💬
|
| 7 | [Bexsero] | - | - | - | - | 2件: 62 62, 223 💬
|
| 8 | [Eculizumab] | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 9 | [LNP023] | - | - | - | - | 2件: 62 62, 66 💬
|
| 10 | [Menveo] | - | - | - | - | 2件: 62 62, 223 💬
|
| 11 | [NA] | - | - | - | - | 34件: 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 12 | [ravulizumab] | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 13 | [REGN3918] | - | - | - | - | 2件: 11 11, 62 💬
|
| 14 | [RO7112689] | - | - | - | - | 1件: 62 62 💬
|
| 15 | [Soliris] | - | - | - | - | 2件: 13 13, 62 💬
|
| 16 | ABP 959 | - | - | - | - | 1件: 62 62 💬
|
| 17 | ABP 959 - biosimilar to eculizumab | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 18 | ABP 959 - proposed biosimilar to eculizumab | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 19 | ACETYLSALICYLIC ACID | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 5件: 13 13, 46, 51, 62, 210 💬
|
| 20 | ACH-0144471 | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | 2件: 62 62, 223 💬
|
| 21 | ACH-0145228 | - | - | - | - | 1件: 62 62 💬
|
| 22 | Act-HiB | - | - | - | - | 3件: 14 14, 62, 223 💬
|
| 23 | ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml | - | - | - | - | 4件: 61 61, 62, 63, 223 💬
|
| 24 | ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML | - | - | - | - | 2件: 62 62, 66 💬
|
| 25 | ADX-038 | - | - | - | - | 2件: 62 62, 223 💬
|
| 26 | Allogeneic Bone Marrow Transplantation | - | - | - | - | 8件: 60 60, 62, 65, 96, 164, 284, 285, 286 💬
|
| 27 | Allogeneic hematopoietic stem cell transplantation | - | - | - | - | 8件: 28 28, 51, 60, 62, 65, 164, 284, 285 💬
|
| 28 | Allogeneic stem cell transplantation | - | - | - | - | 5件: 19 19, 20, 49, 62, 84 💬
|
| 29 | ALN-62643 | - | - | - | - | 1件: 62 62 💬
|
| 30 | ALN-CC5 | - | - | - | - | 4件: 11 11, 62, 66, 109 💬
|
| 31 | ALN-CFB | - | - | - | - | 1件: 62 62 💬
|
| 32 | ALXN1102 | - | - | - | - | 1件: 62 62 💬
|
| 33 | ALXN1103 | - | - | - | - | 1件: 62 62 💬
|
| 34 | ALXN1210 | - | - | - | - | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
| 35 | ALXN2040 | - | - | - | - | 1件: 62 62 💬
|
| 36 | ALXN2040 (ACH-0144471) | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | 1件: 62 62 💬
|
| 37 | ALXN2050 | - | - | - | - | 3件: 11 11, 62, 66 💬
|
| 38 | Anti Haemophilus influeanze vaccination | - | - | - | - | 1件: 62 62 💬
|
| 39 | Anti-C5 antibody | - | - | - | - | 4件: 11 11, 14, 62, 109 💬
|
| 40 | Anti-Thymocyte Globulin | - | - | - | - | 19件: 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
|
| 41 | APL-2 | - | - | - | - | 6件: 2 2, 61, 62, 66, 222, 223 💬
|
| 42 | Aspaveli | - | - | - | - | 4件: 2 2, 61, 62, 223 💬
|
| 43 | BCD-148 | - | - | - | - | 1件: 62 62 💬
|
| 44 | BCX10013 | 1件: BCX10013 BCX10013 | - | - | - | 1件: 62 62 💬
|
| 45 | BCX9930 | - | - | - | - | 4件: 62 62, 66, 222, 223 💬
|
| 46 | BCX9930 hydrochloride | - | - | - | - | 4件: 62 62, 66, 222, 223 💬
|
| 47 | BCX9930 monotherapy | - | - | - | - | 1件: 62 62 💬
|
| 48 | BENZILPENICILLINA BENZATINICA | - | - | - | - | 1件: 62 62 💬
|
| 49 | BENZILPENICILLINA BENZATINICA BIOPHARMA - 1.200.000 UI/2.5 ML SOSPENSIONE INIETTABILE PER USO INTRAMUSCOLARE 1 SIRINGA PRERIEMPITA DA 2.5 ML | - | - | - | - | 1件: 62 62 💬
|
| 50 | Bexsero | - | - | - | - | 4件: 11 11, 13, 62, 223 💬
|
| 51 | BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA P | - | - | - | - | 1件: 62 62 💬
|
| 52 | BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA PRERIEMPITA (VETRO) - 0.5ML - 1 SIRINGA PRERIEMPITA CON AGO | - | - | - | - | 3件: 62 62, 66, 223 💬
|
| 53 | Bexsero sospensione iniettabile in siringa preriempita | - | - | - | - | 1件: 62 62 💬
|
| 54 | BEXSERO – Sospensione iniettabile – Siringa preriempita | - | - | - | - | 4件: 61 61, 62, 63, 223 💬
|
| 55 | Biospecimen Collection | - | - | - | - | 18件: 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
| 56 | Bone Marrow Aspiration | - | - | - | - | 7件: 28 28, 60, 62, 65, 284, 285, 286 💬
|
| 57 | Bone Marrow Biopsy | - | - | - | - | 7件: 26 26, 28, 60, 62, 65, 284, 286 💬
|
| 58 | Bryostatin 1 | 1件: Bryostatin 1 Bryostatin 1 | - | - | - | 2件: 13 13, 62 💬
|
| 59 | C5 inh MAb, SKY59, RO/CH7092230 | - | - | - | - | 2件: 62 62, 109 💬
|
| 60 | C5 Inhibitor | - | - | - | - | 1件: 62 62 💬
|
| 61 | Calcium | 1件: Calcium Calcium | - | - | - | 39件: 2 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
|
| 62 | Campath, Chemo and/or TBI Allo SCT | - | - | - | - | 3件: 60 60, 62, 283 💬
|
| 63 | Carbon-14 labeled HSK39297 | - | - | - | - | 1件: 62 62 💬
|
| 64 | Cell Infusion | - | - | - | - | 3件: 60 60, 62, 283 💬
|
| 65 | Cemdisiran | 1件: Cemdisiran Cemdisiran | - | - | - | 6件: 11 11, 15, 62, 66, 109, 223 💬
|
| 66 | Clopidogrel | 1件: Clopidogrel Clopidogrel | 4件: Clopidogrel bisulfate
Clopidogrel bisulfate
,
Clopidogrel
,
Clopidogrel hydrochloride
,
Clopidogrel besilate
💬
| 1件: P2RY12 P2RY12 💬
| 3件: Efferocytosis Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬 | 7件: 40 40, 49, 51, 62, 71, 86, 222 💬
|
| 67 | CMS-D017 Capsule | - | - | - | - | 1件: 62 62 💬
|
| 68 | Combination Product: Ravulizumab OBDS | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 69 | Combination Product: Standard of Care | - | - | - | - | 1件: 62 62 💬
|
| 70 | Computed Tomography | - | - | - | - | 13件: 26 26, 28, 34, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
|
| 71 | COVERSIN | - | - | - | - | 2件: 62 62, 109 💬
|
| 72 | Crovalimab | 1件: Crovalimab Crovalimab | 1件: Crovalimab
Crovalimab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 48 48, 62, 109 💬
|
| 73 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 50件: 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 74 | Cyclosporin A+Glucocorticoids | - | - | - | - | 2件: 60 60, 62 💬
|
| 75 | Cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 39件: 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 76 | Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant | - | - | - | - | 1件: 62 62 💬
|
| 77 | DANICOPAN | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | 2件: 62 62, 223 💬
|
| 78 | Danicopan (ALXN2040) | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | 1件: 62 62 💬
|
| 79 | Dextran | 1件: Dextran Dextran | 5件: Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| 2件: LIPC LIPC, LPL 💬
| 4件: Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | 5件: 2 2, 62, 79, 96, 97 💬
|
| 80 | EA5 | - | - | - | - | 2件: 48 48, 62 💬
|
| 81 | Echocardiography | - | - | - | - | 6件: 28 28, 60, 62, 65, 284, 286 💬
|
| 82 | ECULIZUMAB | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 8件: 11 11, 13, 14, 61, 62, 109, 221, 223 💬
|
| 83 | Eculizumab Injection | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 84 | Elizaria® | - | - | - | - | 1件: 62 62 💬
|
| 85 | Fc- and CDR-modified humanised monoclonal antibody against C5 | - | - | - | - | 3件: 11 11, 62, 109 💬
|
| 86 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 30件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 87 | Fludarabine | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 30件: 11 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
|
| 88 | Fludarabine phosphate | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 14件: 28 28, 36, 49, 51, 60, 61, 62, 63, 65, 96, 283, 284, 285, 286 💬
|
| 89 | Gelatin | 1件: Gelatin Gelatin | 1件: Gelatin
Gelatin
💬
| - | - | 7件: 28 28, 47, 62, 70, 71, 97, 269 💬
|
| 90 | Glucocorticoids | - | - | - | - | 13件: 35 35, 40, 41, 43, 44, 49, 60, 61, 62, 75, 96, 221, 300 💬
|
| 91 | H5G1.1-mAb | - | - | - | - | 3件: 13 13, 50, 62 💬
|
| 92 | HAEMOPHILUS INFLUENZAE | - | - | - | - | 5件: 61 61, 62, 63, 66, 223 💬
|
| 93 | HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML | - | - | - | - | 5件: 61 61, 62, 63, 66, 223 💬
|
| 94 | HRS-5965 capsule | - | - | - | - | 1件: 62 62 💬
|
| 95 | HRS-5965 Capsules | - | - | - | - | 2件: 62 62, 66 💬
|
| 96 | HRS-5965 tablets | - | - | - | - | 2件: 62 62, 66 💬
|
| 97 | HS-10542 | - | - | - | - | 1件: 62 62 💬
|
| 98 | HSK39297 | - | - | - | - | 2件: 62 62, 66 💬
|
| 99 | HSK39297 tablets | - | - | - | - | 1件: 62 62 💬
|
| 100 | Human monoclonal antibody directed against complement 5 protein | - | - | - | - | 1件: 62 62 💬
|
| 101 | Humanized anti-Factor Bb monoclonal antibody | - | - | - | - | 1件: 62 62 💬
|
| 102 | Iptacopan | 1件: Iptacopan Iptacopan | 2件: Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| 1件: CFB CFB 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | 8件: 11 11, 61, 62, 63, 66, 109, 222, 223 💬
|
| 103 | Iptacopan (LNP023) | 1件: Iptacopan Iptacopan | 2件: Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| 1件: CFB CFB 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬 | 1件: 62 62 💬
|
| 104 | Iron Dextran | 3件: Dextran Dextran, Iron, Iron Dextran | 7件: Dextran 1
Dextran 1
,
Ferrous fumarate
,
Dextran sulfate sodium
,
Iron dextran
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| 2件: LIPC LIPC, LPL 💬
| 4件: Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | 2件: 62 62, 97 💬
|
| 105 | Iron sucrose | 3件: Iron Iron, Iron sucrose, Sucrose | 3件: Sucrose
Sucrose
,
Ferrous fumarate
,
Iron sucrose
💬
| - | - | 3件: 62 62, 96, 97 💬
|
| 106 | KP104 | - | - | - | - | 4件: 49 49, 62, 66, 223 💬
|
| 107 | L04AA25 | - | - | - | - | 1件: 62 62 💬
|
| 108 | Lapine T-Lymphocyte Immune Globulin | - | - | - | - | 4件: 62 62, 65, 284, 286 💬
|
| 109 | Levamisole | 1件: Levamisole Levamisole | 2件: Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | 4件: 60 60, 61, 62, 222 💬
|
| 110 | Levamisole+cyclosporin A+Glucocorticoids | 1件: Levamisole Levamisole | 2件: Levamisole hydrochloride
Levamisole hydrochloride
,
Levamisole
💬
| - | - | 2件: 60 60, 62 💬
|
| 111 | LFG316 | - | - | - | - | 1件: 62 62 💬
|
| 112 | LNP023 | - | - | - | - | 7件: 61 61, 62, 63, 66, 109, 222, 223 💬
|
| 113 | LNP023 HYDROCHLORIDE SALT | - | - | - | - | 2件: 62 62, 223 💬
|
| 114 | LP-005 Dose 1 (Single) | - | - | - | - | 1件: 62 62 💬
|
| 115 | LP-005 Dose 2 (Single) | - | - | - | - | 1件: 62 62 💬
|
| 116 | LP-005 Dose 3 (Single) | - | - | - | - | 1件: 62 62 💬
|
| 117 | LP-005 Dose 4 (Single) | - | - | - | - | 1件: 62 62 💬
|
| 118 | LP-005 Dose 5 (Single) | - | - | - | - | 1件: 62 62 💬
|
| 119 | LP-005 Dose 6 (Single) | - | - | - | - | 1件: 62 62 💬
|
| 120 | LP-005 Dose 7 (Multiple) | - | - | - | - | 1件: 62 62 💬
|
| 121 | LP-005 Dose 8 (Multiple) | - | - | - | - | 1件: 62 62 💬
|
| 122 | LP-005 Dose 9 (Multiple) | - | - | - | - | 1件: 62 62 💬
|
| 123 | LP-005 Injection | - | - | - | - | 1件: 62 62 💬
|
| 124 | Melphalan | 1件: Melphalan Melphalan | 2件: Melphalan
Melphalan
,
Melphalan hydrochloride
💬
| - | - | 19件: 11 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
|
| 125 | Menveo | - | - | - | - | 4件: 11 11, 13, 62, 223 💬
|
| 126 | MENVEO - POLV.E SOLUZ.PER SOLUZ. INIETT.-USO INTRAMUSCOLARE-COMP. CONIUG.LIOFILIZZ.MENA:FLAC.(VETRO) COMP. GONIUG.LIQUI.MENCWY:FLAC.(VETRO)-1 FLAC+1FLAC | - | - | - | - | 3件: 62 62, 66, 223 💬
|
| 127 | Menveo polvere e soluzione per soluzione iniettabile | - | - | - | - | 1件: 62 62 💬
|
| 128 | MENVEO – Polvere e soluzione per soluzione iniettabile | - | - | - | - | 4件: 61 61, 62, 63, 223 💬
|
| 129 | Methotrexate | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR2 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 41件: 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 130 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 51件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 131 | Miltenyi Biotec CliniMACS | - | - | - | - | 2件: 62 62, 326 💬
|
| 132 | Miltenyi CliniMACS | - | - | - | - | 2件: 62 62, 285 💬
|
| 133 | Multigated Acquisition Scan | - | - | - | - | 5件: 60 60, 62, 65, 284, 286 💬
|
| 134 | MY008211A tablets | - | - | - | - | 2件: 62 62, 66 💬
|
| 135 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH1 IMPDH1, IMPDH2 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 38件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 136 | Myeloablative Preparative Regimen | - | - | - | - | 3件: 62 62, 65, 284 💬
|
| 137 | NM8074 | - | - | - | - | 5件: 50 50, 62, 66, 109, 223 💬
|
| 138 | No | - | - | - | - | 3件: 46 46, 62, 299 💬
|
| 139 | Nonmyeloablative allogeneic hematopoietic stem cell transplantation | - | - | - | - | 6件: 28 28, 51, 60, 62, 65, 285 💬
|
| 140 | NTQ5082 100mg qd | - | - | - | - | 1件: 62 62 💬
|
| 141 | NTQ5082 200mg qd | - | - | - | - | 1件: 62 62 💬
|
| 142 | NTQ5082 capsules 200 mg | - | - | - | - | 2件: 62 62, 66 💬
|
| 143 | OMS906 | 1件: OMS906 OMS906 | - | - | - | 2件: 62 62, 223 💬
|
| 144 | OMS906 study drug | 1件: OMS906 OMS906 | - | - | - | 2件: 62 62, 223 💬
|
| 145 | Other: Laboratory Biomarker Analysis | - | - | - | - | 22件: 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
| 146 | Other: Peripheral Blood Stem Cells | - | - | - | - | 2件: 60 60, 62 💬
|
| 147 | Other: Pharmacological Study | - | - | - | - | 7件: 28 28, 34, 62, 74, 89, 232, 331 💬
|
| 148 | Other: Quality-of-Life Assessment | - | - | - | - | 9件: 34 34, 36, 51, 62, 65, 96, 284, 286, 298 💬
|
| 149 | Other: Standard of Care (SOC) | - | - | - | - | 2件: 40 40, 62 💬
|
| 150 | PEGCETACOPLAN | 1件: Pegcetacoplan Pegcetacoplan | 1件: Pegcetacoplan
Pegcetacoplan
💬
| 1件: C3 C3 💬
| 18件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagocytosis, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 4件: 2 2, 61, 62, 223 💬
|
| 151 | Pegcetacoplan (APL-2) | 1件: Pegcetacoplan Pegcetacoplan | 1件: Pegcetacoplan
Pegcetacoplan
💬
| 1件: C3 C3 💬
| 18件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagocytosis, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 3件: 2 2, 61, 62 💬
|
| 152 | Peripheral Blood Stem Cell Transplantation | - | - | - | - | 12件: 11 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
|
| 153 | Pneumovax | - | - | - | - | 5件: 46 46, 49, 62, 96, 223 💬
|
| 154 | PNEUMOVAX - 10 SIRINGHE PRERIEMPITE CON AGO DA 0.5 ML | - | - | - | - | 1件: 62 62 💬
|
| 155 | PNEUMOVAX – Soluzione iniettabile in siringa preriempita da 0,5 ml | - | - | - | - | 2件: 62 62, 66 💬
|
| 156 | POLISACCARIDE DELL'HAEMOPHILUS INFLUENZAE DI TIPO B CONIUGATO CON LA PROTEINA TETANICA | - | - | - | - | 1件: 62 62 💬
|
| 157 | Post-Transplant G-CSF | - | - | - | - | 3件: 60 60, 62, 283 💬
|
| 158 | Pozelimab | 1件: Pozelimab Pozelimab | 1件: Pozelimab
Pozelimab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 11 11, 15, 62 💬
|
| 159 | PREVENAR 13 - 0.5 ML SOSPENSION | - | - | - | - | 1件: 62 62 💬
|
| 160 | RA101495 | - | - | - | - | 1件: 62 62 💬
|
| 161 | RA101495 sodium | - | - | - | - | 1件: 62 62 💬
|
| 162 | Rabbit | 1件: Rabbit Rabbit | - | - | - | 11件: 11 11, 13, 49, 51, 60, 62, 65, 96, 283, 285, 326 💬
|
| 163 | Rabbit ATG | 1件: Rabbit Rabbit | - | - | - | 4件: 60 60, 62, 283, 285 💬
|
| 164 | Radiation: Total Body Irradiation | - | - | - | - | 11件: 19 19, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284 💬
|
| 165 | Radiation: total-body irradiation | - | - | - | - | 9件: 28 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
|
| 166 | RAVULIZUMAB | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 8件: 2 2, 11, 13, 50, 62, 66, 109, 224 💬
|
| 167 | Reduced Intensity Preparative Regimen | - | - | - | - | 3件: 62 62, 65, 284 💬
|
| 168 | Reduced Toxicity Ablative Regimen | - | - | - | - | 3件: 62 62, 65, 284 💬
|
| 169 | REGN3918 | - | - | - | - | 2件: 11 11, 62 💬
|
| 170 | RITUXIMAB | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 54件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 171 | RO7112689 | - | - | - | - | 1件: 62 62 💬
|
| 172 | RO7112689/F01 | - | - | - | - | 1件: 62 62 💬
|
| 173 | RO7112689/F03-01 | - | - | - | - | 2件: 62 62, 109 💬
|
| 174 | RO7112689/F03-03 | - | - | - | - | 1件: 62 62 💬
|
| 175 | RO7112689/F03-10 | - | - | - | - | 2件: 62 62, 109 💬
|
| 176 | Rosuvastatin | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 16件: 6 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
|
| 177 | RVA576 | - | - | - | - | 3件: 62 62, 109, 162 💬
|
| 178 | RVA576 (COVERSIN) | - | - | - | - | 2件: 62 62, 109 💬
|
| 179 | Sargramostim | 1件: Sargramostim Sargramostim | 1件: Sargramostim
Sargramostim
💬
| 1件: CSF2RA CSF2RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 7件: 6 6, 28, 60, 62, 96, 229, 285 💬
|
| 180 | SB12 (proposed eculizumab biosimilar) | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 181 | Sirolimus | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 52件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 46件: 6 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 182 | SLN12140 | - | - | - | - | 2件: 62 62, 66 💬
|
| 183 | Solaris | - | - | - | - | 2件: 62 62, 109 💬
|
| 184 | SOLIRIS | - | - | - | - | 6件: 11 11, 13, 14, 62, 109, 223 💬
|
| 185 | Soliris (eculizumab) | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 186 | SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML) | - | - | - | - | 3件: 13 13, 62, 109 💬
|
| 187 | Soliris 300 | - | - | - | - | 1件: 62 62 💬
|
| 188 | Soliris 300 mg concentrate for solution for infusion | - | - | - | - | 1件: 62 62 💬
|
| 189 | Soliris 300mg/30ml | - | - | - | - | 1件: 62 62 💬
|
| 190 | Soliris ™ (eculizumab) | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 191 | Soliris/Ultomiris | - | - | - | - | 1件: 62 62 💬
|
| 192 | Soliris® | - | - | - | - | 1件: 62 62 💬
|
| 193 | Stem Cell Transplantation | - | - | - | - | 14件: 13 13, 19, 20, 46, 48, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
|
| 194 | Sterile Normal Saline (0.9% NaCl) | - | - | - | - | 4件: 62 62, 79, 234, 254 💬
|
| 195 | Sucrose | 1件: Sucrose Sucrose | 1件: Sucrose
Sucrose
💬
| - | - | 4件: 62 62, 96, 97, 127 💬
|
| 196 | Synthetic 15-amino-acid macrocyclic peptide | - | - | - | - | 1件: 62 62 💬
|
| 197 | Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 | - | - | - | - | 1件: 62 62 💬
|
| 198 | Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 palmitoylated linker | - | - | - | - | 1件: 62 62 💬
|
| 199 | Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker | - | - | - | - | 1件: 62 62 💬
|
| 200 | Systematic chemotherapy and antibodies | - | - | - | - | 1件: 62 62 💬
|
| 201 | Systemic chemotherapy and antibodies | - | - | - | - | 2件: 62 62, 326 💬
|
| 202 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 37件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
| 203 | TETRACT-HIB - 1 SIRINGA PRECARICATA 0.5 ML | - | - | - | - | 2件: 62 62, 223 💬
|
| 204 | TREOSULFAN | 1件: Treosulfan Treosulfan | 1件: Treosulfan
Treosulfan
💬
| - | - | 6件: 13 13, 19, 62, 65, 284, 286 💬
|
| 205 | Tretinoin | 1件: Tretinoin Tretinoin | 1件: Tretinoin
Tretinoin
💬
| 3件: PML PML, RARA, RARB 💬
| 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 4件: 2 2, 62, 63, 75 💬
|
| 206 | Ultomiris | - | - | - | - | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
| 207 | ULTOMIRIS - 300 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 3 ML (100 MG / ML) - 1 FLACONCINO | - | - | - | - | 1件: 62 62 💬
|
| 208 | Ultomiris 300mg/30ml | - | - | - | - | 1件: 62 62 💬
|
| 209 | ULTOMIRIS ™ (ravulizumab-cwvz) | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 210 | VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B | - | - | - | - | 5件: 61 61, 62, 63, 66, 223 💬
|
| 211 | VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON PROTEINA DIFTERICA CRM197 | - | - | - | - | 1件: 62 62 💬
|
| 212 | VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO | - | - | - | - | 5件: 61 61, 62, 63, 66, 223 💬
|
| 213 | VACCINO MENINGOCOCCICO POLISACCARIDICO | - | - | - | - | 1件: 62 62 💬
|
| 214 | VACCINO PNEUMOCOCCICO | - | - | - | - | 2件: 62 62, 66 💬
|
| 215 | VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135) | - | - | - | - | 5件: 61 61, 62, 63, 66, 223 💬
|
| 216 | VARI | - | - | - | - | 2件: 62 62, 274 💬
|
| 217 | VSA012 | - | - | - | - | 1件: 62 62 💬
|
| 218 | Water | 1件: Water Water | 1件: Water
Water
💬
| - | - | 36件: 2 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
|
| 219 | X-Ray Imaging | - | - | - | - | 5件: 28 28, 62, 65, 284, 286 💬
|
| 220 | XH-S003 Capsule | - | - | - | - | 2件: 62 62, 66 💬
|
| 221 | Zilucoplan | 1件: Zilucoplan Zilucoplan | 2件: Zilucoplan sodium
Zilucoplan sodium
,
Zilucoplan
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 2 2, 11, 62 💬
|
| 222 | Zilucoplan (RA101495) | 1件: Zilucoplan Zilucoplan | 2件: Zilucoplan sodium
Zilucoplan sodium
,
Zilucoplan
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 11 11, 62 💬
|
| 223 | LNP023 HYDROCHLORIDE SALT | - | - | - | - | 7件: 61 61, 62, 63, 66, 109, 222, 223 💬
|